Evidence map›Paper›PMID 28077440›Full record

ArticleClinical and vaccine immunology : CVI2017

Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular Immunity.

Katharina Richard, Barbara J Mann, Aiping Qin, Eileen M Barry, Robert K Ernst, Stefanie N Vogel

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical and vaccine immunology : CVI, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Lipid-Based Nanovesicular Drug Delivery Systems.Nanomaterials (Basel, Switzerland) · 2021
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Adaptive Immunity toFrontiers in cellular and infection microbiology · 2018
    Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Katharina RichardDepartment of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Barbara J MannDepartment of Medicine, University of Virginia, Charlottesville, Virginia, USA.
Aiping QinDepartment of Medicine, University of Virginia, Charlottesville, Virginia, USA.
Eileen M BarryCenter for Vaccine Development, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Robert K ErnstDepartment of Microbial Pathogenesis, University of Maryland School of Dentistry, Baltimore, Maryland, USA.
Stefanie N VogelDepartment of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland, USA svogel@som.umaryland.edu.
University of Maryland, Baltimore · USUniversity of Virginia · US

Funding

Signaling Pathways in Innate ImmunityT32AI095190 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI Stefanie N. Vogel · 2012 to 2026
$4.7M
Advancement of a Defined, Protective, Live Attenuated Tularemia VaccineR01AI102966 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI BARRY, EILEEN M. · 2013 to 2015
$2.1M
Differentiative Signals for Macrophage ActivationR56AI018797 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI VOGEL, STEFANIE N. · 2015 to 2015
$506k
Development of a Rationally Attenuated Live Vaccine for Francisella tularensisR21AI101691 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI ERNST, ROBERT K, VOGEL, STEFANIE N. · 2013 to 2014
$422k
NIAID NIH HHS R01 AI102966NIAID NIH HHS R21 AI101691NIAID NIH HHS R56 AI018797NIAID NIH HHS T32 AI095190
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Immunity, CellularImmunity, HumoralAdjuvants, ImmunologicAnimalsAntibodies, BacterialBacterial VaccinesBronchoalveolar Lavage FluidDisease Models, AnimalFemaleFrancisella tularensisImmunoglobulin AImmunoglobulin GInterferon-gammaLipid AMacrophagesMice, Inbred C57BLAdjuvants, ImmunologicAntibodies, BacterialBacterial VaccinesImmunoglobulin AImmunoglobulin GInterferon-gammaLipid Amonophosphoryl lipid AVaccines, Subunitcatanionic surfactantFrancisella tularensisimmunizationLVSmicemonophosphoryl lipid AnanoparticleSchu S4subunit vaccinetularemia

Identifiers

PMID28077440
PMCPMC5339645
OpenAlexW2578462825

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.